Skip to main content
Log in

l-Arginine therapy in Raynaud's phenomenon?

  • Brief Definitive Reports
  • Published:
International Journal of Clinical and Laboratory Research

Summary

Sincel-Arginine is the substrate for nitric oxide synthesis by vascular endothelial cells the effects ofl-arginine treatment on the digital vascular response to local stimuli were investigated in patients with primary or secondary Raynaud's phenomenon. After therapy, patients withu Raynaud's phenomenon secondary to systemic sclerosis showed: (1) higher digital vasodilation after local warming, (2) cold-induced digital vasodilation, and (3) increase of plasma levels of tissue-type plasminogen activator.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Faraci FM, Mayhan WG, Heistad DD, Endothelium-dependent responses of cerebral blood vessels in vivo. In: Rubanyi GM, Vanhoutte PM (eds) Endothelium-derived relaxing factors. Karger, Basel, p. 185, 1990

    Google Scholar 

  2. Fritzler MJ, Hart DA, Prolonged improvement of Raynaud's phenomenon and scleroderma after recombinant tissue plasminogen activator therapy. Arthritis Rheum 33:274, 1990

    Article  PubMed  CAS  Google Scholar 

  3. Girerd XJ, Hirsch T, Cooke P, Dzau J, Creager MA,l-Arginine augments endothelium-dependent vasodilation in cholesterolfed rabbits. Circ Res 67:1301, 1990

    PubMed  CAS  Google Scholar 

  4. Hishikawa K, Nakaki T, Suzuki H, Saruta T, Kato R,l-Arginine-induced hypotension. Lancet I:683, 1991

    Article  Google Scholar 

  5. Ignarro LJ, Gold ME, Alteration of endothelium-dependent arterial relaxation by arginine analogs and arginine depletion. In: Rubanyi GM, Vanhoutte PM (eds) Endothelium-derived relaxing factors. Karger, Basel, p 64, 1990

    Google Scholar 

  6. Marasini B, Cugno M, Agostoni A, Plasma levels of tissue-type plasminogen activator and von Willebrand factor in patients with Raynaud's phenomenon. Arthritis Rheum 34:255, 1991

    Article  PubMed  CAS  Google Scholar 

  7. Palmer RMJ, Ashton DS, Moncada S, Vascular endothelial cells synthesize nitric oxide froml-arginine. Nature 327:524, 1987

    Article  PubMed  CAS  Google Scholar 

  8. Rodnan GP, Myerowitz RL, Justh GO, Morphologic changes in the digital arteries of patients with progressive systemic sclerosis (scleroderma) and Raynaud's phenomenon. Medicine 59:393, 1980

    Article  PubMed  CAS  Google Scholar 

  9. Vallance P, Collier J, Moncada S, Effects of endothelium-derived nitric oxide on peripheral arteriolar tone in man. Lancet II:997, 1989

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Agostoni, A., Marasini, B., Biondi, M.L. et al. l-Arginine therapy in Raynaud's phenomenon?. Int J Clin Lab Res 21, 202–203 (1992). https://doi.org/10.1007/BF02591645

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02591645

Key words

Navigation